Literature for inhibitor I04.002: alpha-1-antichymotrypsin

Summary Gene structure Alignment Tree Sequences Sequence features Distribution Structure Literature

(Topics flags: S Structure, M Mutation, I Inhibitor, K Knockout, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2025
  1. Zhang,G., Sun,X., Zhang,D., Zhang,X. and Yu,K.
    SerpinA3 Promotes Myocardial Infarction in Rat and Cell-based Models
    Mol Biotechnol67, 92-103. PubMed  Europe PubMed DOI
  2. 2024
  3. Barter,M.J., Turner,D.A., Rice,S.J., Hines,M., Lin,H., Falconer,A.M.D., McDonnell,E., Soul,J., Del Carmen Arques,M., Europe-Finner,G.N., Rowan,A.D., Young,D.A. and Wilkinson,D.J.
    SERPINA3 is a marker of cartilage differentiation and is essential for the expression of extracellular matrix genes during early chondrogenesis
    Matrix Biol133, 33-42. PubMed  Europe PubMed DOI  K
  4. Kontoh-Twumasi,R., Budkin,S., Edupuganti,N., Vashishtha,A. and Sharma,S.
    Role of Serine Protease Inhibitors A1 and A3 in Ocular Pathologies
    Invest Ophthalmol Vis Sci65, 16-16. PubMed  Europe PubMed DOI  V
  5. 2022
  6. Fatima,S., Gupta,S., Khan,A.B., Rehman,S.U. and Jairajpuri,M.A.
    Identification and validation of two alternatively spliced novel isoforms of human alpha-1-antichymotrypsin
    Biochem Biophys Res Commun628, 25-31. PubMed  Europe PubMed DOI
  7. Jin,Y., Wang,W., Wang,Q., Zhang,Y., Zahid,K.R., Raza,U. and Gong,Y.
    Alpha-1-antichymotrypsin as a novel biomarker for diagnosis, prognosis, and therapy prediction in human diseases
    Cancer Cell Int22, 156-156. PubMed  Europe PubMed DOI  V
  8. 2021
  9. Li,B., Lei,Z., Wu,Y., Li,B., Zhai,M., Zhong,Y., Ju,P., Kou,W., Shi,Y., Zhang,X. and Peng,W.
    The Association and Pathogenesis of SERPINA3 in Coronary Artery Disease
    Front Cardiovasc Med8, 756889-756889. PubMed  Europe PubMed DOI  K
  10. 2020
  11. Koivuluoma,S., Tervasmaki,A., Kauppila,S., Winqvist,R., Kumpula,T., Kuismin,O., Moilanen,J. and Pylkas,K.
    Exome sequencing identifies a recurrent variant in SERPINA3 associating with hereditary susceptibility to breast cancer
    Eur J Cancer143, 46-51. PubMed  Europe PubMed DOI
  12. Sanchez-Navarro,A., Gonzalez-Soria,I., Caldino-Bohn,R. and Bobadilla,N.A.
    Integrative view of serpins in health and disease: the contribution of serpinA3
    Am J Physiol Cell Physiol PubMed  Europe PubMed DOI  V
  13. 2016
  14. Madsen,J.B., Andersen,L.M., Dupont,D.M., Trelle,M.B., Johansen,J.S., Jensen,J.K., Jorgensen,T.J. and Andreasen,P.A.
    An RNA aptamer inhibits a mutation-induced inactivating misfolding of a serpin
    Cell Chem Biol23, 700-708. PubMed  Europe PubMed DOI  I
  15. 2015
  16. Marcet-Palacios,M., Ewen,C., Pittman,E., Duggan,B., Carmine-Simmen,K., Fahlman,R.P. and Bleackley,R.C.
    Design and characterization of a novel human granzyme B inhibitor
    Protein Eng Des Sel28, 9-17. PubMed  Europe PubMed DOI
  17. 2013
  18. Santamaria,M., Pardo-Saganta,A., Alvarez-Asiain,L., Di Scala,M., Qian,C., Prieto,J. and Avila,M.A.
    Nuclear alpha1-antichymotrypsin promotes chromatin condensation and inhibits proliferation of human hepatocellular carcinoma cells
    Gastroenterology144, 818-828. PubMed  Europe PubMed DOI
  19. Zhu,L., Jaamaa,S., Af Hallstrom,T.M., Laiho,M., Sankila,A., Nordling,S., Stenman,U.H. and Koistinen,H.
    PSA forms complexes with alpha1-antichymotrypsin in prostate
    Prostate73, 219-226. PubMed  Europe PubMed DOI
  20. 2011
  21. Hoffmann,D.C., Textoris,C., Oehme,F., Klaassen,T., Goppelt,A., Romer,A., Fugmann,B., Davidson,J.M., Werner,S., Krieg,T. and Eming,S.A.
    Pivotal role for alpha1-antichymotrypsin in skin repair
    J Biol Chem286, 28889-28901. PubMed  Europe PubMed DOI
  22. Wladyka,B., Kozik,A.J., Bukowski,M., Rojowska,A., Kantyka,T., Dubin,G. and Dubin,A.
    alpha1-Antichymotrypsin inactivates staphylococcal cysteine protease in cross-class inhibition
    Biochimie93, 948-953. PubMed  Europe PubMed DOI
  23. 2010
  24. Pearce,M.C., Powers,G.A., Feil,S.C., Hansen,G., Parker,M.W. and Bottomley,S.P.
    Identification and characterization of a misfolded monomeric serpin formed at physiological temperature
    J Mol Biol403, 459-467. PubMed  Europe PubMed DOI
  25. 2009
  26. Zamolodchikova,T.S., Popykina,N.A., Gladysheva,I.P. and Larionova,N.I.
    Effect of reactive center loop structure of antichymotrypsin on inhibition of duodenase activity
    Biochemistry (Mosc)74, 824-833. PubMed  Europe PubMed DOI
  27. 2008
  28. Manolov,T., Forsgren,A. and Riesbeck,K.
    Purification of alpha1-antichymotrypsin from human plasma with recombinant M. catarrhalis ubiquitous surface protein A1
    J Immunol Methods333, 180-185. PubMed  Europe PubMed DOI
  29. Pelissier,P., Delourme,D., Germot,A., Blanchet,X., Becila,S., Maftah,A., Leveziel,H., Ouali,A. and Bremaud,L.
    An original SERPINA3 gene cluster: elucidation of genomic organization and gene expression in the Bos taurus 21q24 region
    BMC Genomics9, 151-151. PubMed  Europe PubMed DOI
  30. 2007
  31. Baker,C., Belbin,O., Kalsheker,N. and Morgan,K.
    SERPINA3 (aka alpha-1-antichymotrypsin)
    Front Biosci12, 2821-2835. PubMed  Europe PubMed DOI  V
  32. Chelbi,S.T., Mondon,F., Jammes,H., Buffat,C., Mignot,T.M., Tost,J., Busato,F., Gut,I., Rebourcet,R., Laissue,P., Tsatsaris,V., Goffinet,F., Rigourd,V., Carbonne,B., Ferre,F. and Vaiman,D.
    Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia
    Hypertension49, 76-83. PubMed  Europe PubMed DOI
  33. Krischek,B., Akagawa,H., Tajima,A., Narita,A., Kasuya,H., Hori,T. and Inoue,I.
    The alanine/threonine polymorphism of the alpha-1-antichymotrypsin (SERPINA3) gene and ruptured intracranial aneurysms in the Japanese population
    Cerebrovasc Dis23, 46-49. PubMed  Europe PubMed DOI  M
  34. 2006
  35. Felber,L.M., Kundig,C., Borgono,C.A., Chagas,J.R., Tasinato,A., Jichlinski,P., Gygi,C.M., Leisinger,H.J., Diamandis,E.P., Deperthes,D. and Cloutier,S.M.
    Mutant recombinant serpins as highly specific inhibitors of human kallikrein 14
    FEBS J273, 2505-2514. PubMed  Europe PubMed DOI
  36. 2005
  37. Slowik,A., Borratynska,A., Turaj,W., Pera,J., Dziedzic,T., Figlewicz,D.A., Betlej,M., Krzyszkowski,T., Czepko,R. and Szczudlik,A.
    Alpha1-antichymotrypsin gene (SERPINA3) A/T polymorphism as a risk factor for aneurysmal subarachnoid hemorrhage
    Stroke36, 737-740. PubMed  Europe PubMed DOI  M
  38. 2004
  39. Cloutier,S.M., Kundig,C., Felber,L.M., Fattah,O.M., Chagas,J.R., Gygi,C.M., Jichlinski,P., Leisinger,H.J. and Deperthes,D.
    Development of recombinant inhibitors specific to human kallikrein 2 using phage-display selected substrates
    Eur J Biochem271, 607-613. PubMed  Europe PubMed DOI
  40. [YEAR:12-11-2004]Pearce,M.C., Cabrita,L.D., Rubin,H., Gore,M.G. and Bottomley,S.P.
    Identification of residual structure within denatured antichymotrypsin: implications for serpin folding and misfolding
    Biochem Biophys Res Commun324, 729-735. PubMed  Europe PubMed DOI
  41. 2003
  42. [YEAR:4-3-2003]Crowther,D.C., Serpell,L.C., Dafforn,T.R., Gooptu,B. and Lomas,D.A.
    Nucleation of alpha1-antichymotrypsin polymerization
    Biochemistry42, 2355-2363. PubMed  Europe PubMed DOI
  43. Forsyth,S., Horvath,A. and Coughlin,P.
    A review and comparison of the murine alpha1-antitrypsin and alpha1-antichymotrypsin multigene clusters with the human clade A serpins
    Genomics81, 336-345. PubMed  Europe PubMed DOI
  44. Hutchinson,S., Luo,L.Y., Yousef,G.M., Soosaipillai,A. and Diamandis,E.P.
    Purification of human kallikrein 6 from biological fluids and identification of its complex with alpha(1)-antichymotrypsin
    Clin Chem49, 746-751. PubMed  Europe PubMed DOI
  45. [YEAR:1-4-2003]Morris,E.C., Dafforn,T.R., Forsyth,S.L., Missen,M.A., Horvath,A.J., Hampson,L., Hampson,I.N., Currie,G., Carrell,R.W. and Coughlin,P.B.
    Murine serpin 2A is a redox-sensitive intracellular protein
    Biochem J371, 165-173. PubMed  Europe PubMed DOI
  46. 2002
  47. Chowanadisai,W. and Lonnerdal,B.
    Alpha(1)-antitrypsin and antichymotrypsin in human milk: origin, concentrations, and stability
    Am J Clin Nutr76, 828-833. PubMed  Europe PubMed
  48. [YEAR:16-8-2002]Plotnick,M.I., Rubin,H. and Schechter,N.M.
    The effects of reactive site location on the inhibitory properties of the serpin alpha(1)-antichymotrypsin
    J Biol Chem277, 29927-29935. PubMed  Europe PubMed DOI
  49. Wang,X., DeKosky,S.T., Luedecking-Zimmer,E., Ganguli,M. and Kamboh,M.I.
    Genetic variation in alpha(1)-antichymotrypsin and its association with Alzheimer's disease
    Hum Genet110, 356-365. PubMed  Europe PubMed DOI  M
  50. 2000
  51. Gooptu,B., Hazes,B., Chang,W.S., Dafforn,T.R., Carrell,R.W., Read,R.J. and Lomas,D.A.
    Inactive conformation of the serpin alpha(1)-antichymotrypsin indicates two-stage insertion of the reactive loop: implications for inhibitory function and conformational disease
    Proc Natl Acad Sci U S A97, 67-72. PubMed  Europe PubMed  S
  52. Pimenta,D.C., Chen,V.C., Chao,J., Juliano,M.A. and Juliano,L.
    Alpha1-antichymotrypsin and kallistatin hydrolysis by human cathepsin D
    J Protein Chem19, 411-418. PubMed  Europe PubMed DOI
  53. 1998
  54. Lukacs,C.M., Rubin,H. and Christianson,D.W.
    Engineering an anion-binding cavity in antichymotrypsin modulates the "spring-loaded" serpin-protease interaction
    Biochemistry37, 3297-3304. PubMed  Europe PubMed DOI  S
  55. 1997
  56. [YEAR:1-1-1997]Hampson,I.N., Hampson,L., Pinkoski,M., Cross,M., Heyworth,C.M., Bleackley,R.C., Atkinson,E. and Dexter,T.M.
    Identification of a serpin specifically expressed in multipotent and bipotent hematopoietic progenitor cells and in activated T cells
    Blood89, 108-118. PubMed  Europe PubMed
  57. 1996
  58. Villoutreix,B.O., Lilja,H., Pettersson,K., Lovgren,T. and Teleman,O.
    Structural investigation of the alpha-1-antichymotrypsin:prostate-specific antigen complex by comparative model building
    Protein Sci5, 836-851. PubMed  Europe PubMed DOI
  59. 1991
  60. Baumann,U., Huber,R., Bode,W., Grosse,D., Lesjak,M. and Laurell,C.B.
    Crystal structure of cleaved human alpha1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins
    J Mol Biol218, 595-606. PubMed  Europe PubMed  S
  61. Inglis,J.D. and Hill,R.E.
    The murine Spi-2 proteinase inhibitor locus: a multigene family with a hypervariable reactive site domain
    EMBO J10, 255-261. PubMed  Europe PubMed
  62. Mast,A.E., Enghild,J.J., Nagase,H., Suzuki,K., Pizzo,S.V. and Salvesen,G.
    Kinetics and physiologic relevance of the inactivation of alpha1- proteinase inhibitor, alpha1-antichymotrypsin, and antithrombin III by matrix metalloproteinases-1 (tissue collagenase), -2 (72-kDa gelatinase/type IV collagenase), and -3 (stromelysin)
    J Biol Chem266, 15810-15816. PubMed  Europe PubMed
  63. [YEAR:15-11-1991]Potempa,J., Fedak,D., Dubin,A., Mast,A. and Travis,J.
    Proteolytic inactivation of alpha-1-anti-chymotrypsin. Sites of cleavage and generation of chemotactic activity
    J Biol Chem266, 21482-21487. PubMed  Europe PubMed
  64. 1990
  65. Christensson,A., Laurell,C.B. and Lilja,H.
    Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors
    Eur J Biochem194, 755-763. PubMed  Europe PubMed
  66. 1983
  67. [YEAR:25-10-1983]Chandra,T., Stackhouse,R., Kidd,V.J., Robson,K.J. and Woo,S.L.
    Sequence homology between human alpha 1-antichymotrypsin, alpha 1-antitrypsin, and antithrombin III
    Biochemistry22, 5055-5061. PubMed  Europe PubMed
  68. [YEAR:10-11-1983]Morii,M. and Travis,J.
    Amino acid sequence at the reactive site of human alpha 1-antichymotrypsin
    J Biol Chem258, 12749-12752. PubMed  Europe PubMed
  69. [YEAR:16-3-1983]Morii,M. and Travis,J.
    Structural alterations in alpha 1-antichymotrypsin from normal and acute phase human plasma
    Biochem Biophys Res Commun111, 438-443. PubMed  Europe PubMed
  70. 1978
  71. [YEAR:26-12-1978]Travis,J., Garner,D. and Bowen,J.
    Human alpha-1-antichymotrypsin: purification and properties
    Biochemistry17, 5647-5651. PubMed  Europe PubMed